Skip to main content

BARCLAYS PLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in HALO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,489,228
-$3,444,988 QoQ
Shares Held
193,242
-18.4% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Derivatives in HALO

reported options exposure · as of Mar 31, 2026
CallValue
$1,047,006
CallShares
16,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. HALO ranks #24 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,047,006 16,200
2026-03-31 $12,489,228 193,242
2025-12-31 $15,934,216 236,764
2025-09-30 $22,605,073 308,223
2025-06-30 $15,373,729 295,535
2025-03-31 $15,947,266 249,918
2024-12-31 $16,733,020 349,990
2024-09-30 $17,511,947 305,939
2024-06-30 $8,035,426 153,465
2024-03-31 $11,576,672 284,579
2023-12-31 $15,179,396 410,698
2023-09-30 $8,188,246 214,352
2023-06-30 $10,129,248 280,822
2023-03-31 $7,432,842 194,628
2022-12-31 $6,637,612 116,654
2022-09-30 $4,404,201 111,386
2022-06-30 $1,606,484 36,511
2022-03-31 $2,968,985 74,448
2021-12-31 $8,599,993 213,877
2021-09-30 $5,467,432 134,401
2021-06-30 $5,827,827 128,338
2021-03-31 $10,011,560 240,143
2020-12-31 $7,605,454 178,072
2020-09-30 $6,176,772 235,037
2020-06-30 $5,998,040 223,724
2020-03-31 $2,851,144 158,485